BRNS
Barinthus Biotherapeutics plc
NASDAQ: BRNS · HEALTHCARE · BIOTECHNOLOGY
$0.60
-1.66% today
Updated 2026-04-29
Market cap
$26.23M
P/E ratio
—
P/S ratio
2.17x
EPS (TTM)
$-1.64
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Barinthus Biotherapeutics plc (BRNS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $19.04M | $50.67M | $280.71M | $270.20M | $214.51M | $160.33M |
| Cash & equivalents | $11.43M | $43.27M | $214.05M | $194.38M | $142.09M | $110.66M |
| Current assets | $16.25M | $47.90M | $226.76M | $213.04M | $156.91M | $125.74M |
| Total liabilities | $41.12M | $53.81M | $28.15M | $27.00M | $27.51M | $30.19M |
| Current liabilities | $5.75M | $7.64M | $11.16M | $12.24M | $12.60M | $15.66M |
| Long-term debt | — | $44.70M | — | — | — | — |
| Shareholder equity | $-22.45M | $-3.54M | $252.13M | $242.90M | $186.78M | $130.03M |
| Retained earnings | $-37.89M | $-57.72M | $-108.58M | $-103.24M | $-176.59M | $-237.66M |
| Accounts receivable | $3.91M | $518000.00 | $11.72M | $18.05M | $7.94M | $13.00M |
| Inventory | — | — | — | — | $1.00 | — |
| Goodwill | — | $0.00 | $12.63M | $12.21M | $12.21M | $0.00 |